SEC Form 4 · accession 0001645627-17-000127
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Oct 9, 2017
Accepted (ET)
Oct 13, 2017 · 9:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 9, 2017 | P | 2,000 | $0.0837 | A | 23,753,189 | D | |
| Common Stock | Oct 9, 2017 | P | 2,000 | $0.0824 | A | 23,755,189 | D | |
| Common Stock | Oct 10, 2017 | P | 3,000 | $0.0895 | A | 23,758,189 | D | |
| Common Stock | Oct 10, 2017 | P | 2,000 | $0.0842 | A | 23,760,189 | D | |
| Common Stock | Oct 10, 2017 | P | 2,000 | $0.0838 | A | 23,762,189 | D | |
| Common Stock | Oct 10, 2017 | P | 50 | $0.0838 | A | 23,762,239 | D | |
| Common Stock | Oct 10, 2017 | P | 1,950 | $0.084 | A | 23,764,189 | D | |
| Common Stock | Oct 10, 2017 | P | 2,000 | $0.0838 | A | 23,766,189 | D | |
| Common Stock | Oct 12, 2017 | P | 3,000 | $0.0735 | A | 23,769,189 | D | |
| Common Stock | Oct 12, 2017 | P | 2,000 | $0.0895 | A | 23,771,189 | D | |
| Common Stock | Oct 12, 2017 | P | 2,000 | $0.0888 | A | 23,773,189 | D | |
| Common Stock | Oct 12, 2017 | P | 2,000 | $0.0885 | A | 23,775,189 | D |
Table II — derivative securities
No Table II lines on this filing.